Danny is the Head of Corporate Development at , a spin-off of Samsung exploring the intersection of healthcare and technology. WELT creates personalized digital therapeutics that combine our expertise in sensor and digital biomarker technologies with therapeutic contents for the treatment of diseases with a high unmet medical need.
He's an advisor to several early-stage startups and family offices pertaining to their healthcare tech investments. Danny also invests in early-stage startups as an angel investor and as a syndicate (Notable Exit: VUNO IPO'21) Danny's a Forbes 30 Under 30 Fellow, ’s Top Rising Star in Tech, a mentor at , and a novice barista.
Please feel free to use any of the following images for print/presentation: